103978-12-7 = 87199-15-3 反应条件:1.1 Reagents: Butyllithium Solvents: Tetrahydrofuran; 30 Min,-78 °C1.2 20 Min,-78 °C; -78 °C -> Rt; 2.5 H,Rt1.3 Reagents: Trifluoroacetic Acid Solvents: Acetonitrile,Water 标题:Design And Synthesis Of Novel Meta-Linked Phenylglycine Macrocyclic Fviia Inhibitors 作者:Richter,Jeremy M.; Et Al 参考文献:Acs Medicinal Chemistry Letters 日期:2017 卷标:8(1) 页码:67-72]
15852-73-0 = 87199-15-3 反应条件:1.1 Reagents: Butyllithium Solvents: Tetrahydrofuran,Hexane; 13 S,0 °C 标题:Effective Utilization Of Flow Chemistry: Use Of Unstable Intermediates,Inhibition Of Side Reactions,And Scale-Up For Boronic Acid Synthesis 作者:Usutani,Hirotsugu; Et Al 参考文献:Organic Process Research & Development 日期:2018 卷标:22(6) 页码:741-746]
15852-73-0 = 87199-15-3 反应条件:1.1 Reagents: Butyllithium1.2 Reagents: Trimethyl Borate1.3 Reagents: Hydrochloric Acid Solvents: Water 标题:Glycomimetic Selectin Inhibitors: (α-D-Mannopyranosyloxy)Methylbiphenyls 作者:Dupre,Brian; Et Al 参考文献:Bioorganic & Medicinal Chemistry Letters 日期:1996 卷标:6(5) 页码:569-72]
18162-48-6 + 15852-73-0 = 87199-15-3 反应条件:1.1 Reagents: Imidazole Solvents: Dichloromethane; 2 H,Rt2.1 Reagents: Butyllithium Solvents: Tetrahydrofuran; 30 Min,-78 °C2.2 20 Min,-78 °C; -78 °C -> Rt; 2.5 H,Rt2.3 Reagents: Trifluoroacetic Acid Solvents: Acetonitrile,Water 标题:Design And Synthesis Of Novel Meta-Linked Phenylglycine Macrocyclic Fviia Inhibitors 作者:Richter,Jeremy M.; Et Al 参考文献:Acs Medicinal Chemistry Letters 日期:2017 卷标:8(1) 页码:67-72
专利号:US-12150934-B2 优先权日:2016-11-30 标 题 :Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases 发明人:SIDDIQUI ARSHAD M; CIBLAT STEPHANE; CONSTANTINEAU-FORGET LEA; GRAND-MAITRE CHANTAL; GUO XIANGYU; SRIVASTAVA SANJAY; SHIPPS GERALD W; COOPER ALAN B; OZA VIBHA; KOSTURA MATTHEW W; LUTHER MICHAEL; LEVINE JEDD 权利人:BANTAM PHARMACEUTICAL LLC 摘要:Disclosed are methods of treating hyperproliferative disorders such as cancer, methods of arresting the cell cycle in cancer cells, methods of inhibiting glutathione synthesis in cancer cells, and associated compounds for use and uses in medicaments. In certain embodiments, the methods, uses and compounds are provided with reference to compounds of the structural formula (I), in which X1, X2, Z1, Z2, the ring system denoted by “aâ€?, R1, L1, L2, Q, L3, R3, L4, R4, L5, and R5 are as described herein. In certain embodiments, compounds disclosed herein are especially active against cancers having a mutant KRAS gene.
专利号:US-8338451-B2 优先权日:2008-03-21 标 题 :Polysubstituted derivatives of 2-heteroaryl-6-phenylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof 发明人:DE PERETTI DANIELLE; EVANNO YANNICK; LARDENOIS PATRICK; MACHNIK DAVID; RAKOTOARISOA NATHALIE; ALMARIO GARCIA ANTONIO 权利人:DE PERETTI DANIELLE; EVANNO YANNICK; LARDENOIS PATRICK; MACHNIK DAVID; RAKOTOARISOA NATHALIE; ALMARIO GARCIA ANTONIO; SANOFI SA 摘要:Compounds of formula (I): n nwherein R, R 1 , R 2 , R 3 , R 4 and X are as defined in the disclosure, or an acid addition salt thereof, and the therapeutic use and process of synthesis thereof.
专利号:US-2009227575-A1 优先权日:2008-03-04 标 题 :7H-PYRROLO[2,3-H]QUINAZOLINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESIS 发明人:VENKATESAN ARANAPAKAM MUDUMBAI; CHEN ZECHENG; DOS SANTOS OSVALDO; BROOIJMANS NATASJA; GOPALSAMY ARIAMALA 权利人:WYETH CORP 摘要:A 7H-pyrrolo[2,3-h]quinazoline compound of the formula I n n n n n n n n n n wherein Ar, R 1 , R 2 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , and n are as defined in the specification, and methods for making same.
专利号:US-9938258-B2 优先权日:2012-11-29 标 题:Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof 发明人:BALOGLU ERKAN; SHECHTER SHARON; SHACHAM SHARON; MCCAULEY DILARA; SENAPEDIS WILLIAM; GOLAN GALI; KALID ORI 权利人:KARYOPHARM THERAPEUTICS INC 摘要:The invention generally relates to substituted 2,3-dihydrobenzofuranyl compounds, and more particularly to a compound represented by Structural Formula I: n nor a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.
专利号:US-2009137557-A1 优先权日:2005-11-22 标题 :Calcilytic Compounds 发明人:KU THOMAS WEN FU; LIN HONG; LUENGO JUAN I; MARQUIS JR ROBERT W; RAMANJULU JOSHI M; TROUT ROBERT; YAMASHITA DENNIS S 权利人:KU THOMAS WEN FU; LIN HONG; LUENGO JUAN I; MARQUIS JR ROBERT W; RAMANJULU JOSHI M; TROUT ROBERT; YAMASHITA DENNIS S 摘要:Novel calcilytic compounds, pharmaceutical compositions, methods of synthesis and methods of using them are provided.
专利号:US-8633204-B2 优先权日:2006-09-15 标 题 :4-methylpyridopyrimidinone compounds 发明人:CHENG HENGMIAO; BHUMRALKAR DILIP; DRESS KLAUS RUPRECHT; HOFFMAN JACQUI ELIZABETH; JOHNSON MARY CATHERINE; KANIA ROBERT STEVEN; LE PHUONG THI QUY; NAMBU MITCHELL DAVID; PAIRISH MASON ALAN; PLEWE MICHAEL BRUNO; TRAN KHANH TUAN 权利人:CHENG HENGMIAO; BHUMRALKAR DILIP; DRESS KLAUS RUPRECHT; HOFFMAN JACQUI ELIZABETH; JOHNSON MARY CATHERINE; KANIA ROBERT STEVEN; LE PHUONG THI QUY; NAMBU MITCHELL DAVID; PAIRISH MASON ALAN; PLEWE MICHAEL BRUNO; TRAN KHANH TUAN; PFIZER 摘要:The present invention is directed to novel 4-methylpyridopyrimidinone compounds of Formula (I), n nand to salts thereof, their synthesis, and their use as inhibitors of phosphoinositide 3-kinase alpha (PI3-Kα).
摘要:Sato, N., Science of Synthesis Knowledge Updates, (2011) 4, 293. 摘要:Werner, E. W.; Sigman, M. S., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 3, 82. 摘要:Kleemann A., Kutscher B., Reichert D., Bossart M., Pharmaceutical Substances, Thieme [Online], Stuttgart, (2025). 摘要:Kleemann A., Kutscher B., Reichert D., Bossart M., Pharmaceutical Substances, Thieme [Online], Stuttgart, (2025).